arrow
S

Shinnosuke Takemoto

Nagasaki University Hospital
H指数:12
被引数:530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Leptomeningeal Metastasis After Resected Lung Adenocarcinoma: A Case Report Highlighting Dynamic Diagnostic Reassessment

脑淀粉样血管病相关炎症模拟脑膜转移:一例切除后肺腺癌病例报告强调动态诊断再评估

2026-09-170
OA
Real-world pharmacokinetics of ramucirumab in combination with erlotinib and docetaxel for advanced non-small cell lung cancer: a prospective cohort study

曲妥珠单抗与厄洛替尼和多西他赛联合治疗晚期非小细胞肺癌的真实世界药代动力学:一项前瞻性队列研究

2026-09-090
OA
Marine-derived surfactin derivatives suppress collagen production and interfere with the HSP47-collagen interaction in preclinical models

海洋来源的表面活性素衍生物在临床前模型中抑制胶原蛋白产生并干扰HSP47-胶原蛋白相互作用

2026-04-280
OAAI
Regression of a Non-Irradiated Lung Adenocarcinoma During Glioblastoma-Directed Chemoradiotherapy: A Case Report

非照射肺癌腺癌在针对胶质母细胞瘤的放化疗期间的消退:一例病例报告

2026-04-040
OAAI
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer

I期研究:阿莫福林联合顺铂及同期加速超分割胸腔放疗治疗局限期小细胞肺癌

2026-02-080
PRE
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting

真实世界中,一线乐伐替尼治疗晚期或复发性胸腺癌的疗效与安全性研究

2026-02-070
OAAI
Multicenter real-world data on first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer and performance status 2: WJOG18424L

多中心真实世界数据:关于晚期非小细胞肺癌且体力状态为2级的患者的一线化疗联合免疫治疗,WJOG18424L

2025-12-090
PRE
Acute amivantamab-induced myocardial injury in a patient with epidermal growth factor receptor-mutant lung cancer: a first case report

表皮生长因子受体突变型肺癌患者中急性amivantamab诱导的心肌损伤:首例病例报告

2025-12-090
OAAI
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET

一项关于卡铂联合nab-紫杉醇在化疗初治性晚期或复发性胸腺上皮肿瘤中的疗效和安全性的II期临床试验:Nab-TET方案

2025-09-300
PRE
Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab

培美曲塞联合铂类药物作为接受纳武利尤单抗联合伊匹木单抗治疗的患者中,恶性胸膜间皮瘤的二线治疗方案。

2025-08-120
PRE
Lamellarin D Acts as an Inhibitor of Type I Collagen Production
2025-02-100
PRE
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
2024-11-011
PRE
Favorable impact of azithromycin on patients in the intensive care unit with coronavirus disease 2019: Insights from the first wave using a Japanese database
2024-11-011
PRE
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)

ramucirumab和多西他赛用于先前接受铂类治疗的非小细胞肺癌和恶性胸腔积液患者的II期研究 (PLEURAM研究)

2024-10-010
OAAI
Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients
2024-05-202
PRE
Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients
2023-08-241
OAAI